Product Information
KONVOMEP 2-84 MG/ML ORAL SUSP is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $2.0834 per ML under NDC 65628027203. Its NADAC has been published 162 times since Jul 19, 2023.
FDA first approved this application on Aug 30, 2022.
Manufacturer
Azurity Pharmaceuticals Inc.NDC
65628027203
Classification
Brand
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
New Drug (NDA)
FDA Application
NDA213593FDA Approved
8/30/2022
On Market Since
2/15/2023
Price Statistics
The NADAC for KONVOMEP 2-84 MG/ML ORAL SUSP has been published 162 times since Jul 19, 2023, and over the history we have for it it has risen 12.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0834 per ML |
|---|---|
| All-time high | $2.0875 (May 13, 2026) |
| All-time low | $1.8596 (Jul 19, 2023) |
| 52-week high | $2.0875 |
| 52-week low | $2.0255 |
| Median price | $2.0240 |
| Average price | $1.9590 |
| Largest weekly change | +9.0% (Jan 15, 2025) |
| Weeks tracked | 162 |
| Tracking since | Jul 19, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 40% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of KONVOMEP 2-84 MG/ML ORAL SUSP?
The current National Average Drug Acquisition Cost (NADAC) for KONVOMEP 2-84 MG/ML ORAL SUSP, manufactured by Azurity Pharmaceuticals Inc., is $2.0834 per ML (NDC 65628027203), effective Aug 19, 2026.
How has the price of KONVOMEP 2-84 MG/ML ORAL SUSP changed over time?
Over the history we have for it, the NADAC for KONVOMEP 2-84 MG/ML ORAL SUSP has risen 12.0%. It has been tracked across 162 weekly CMS publications since Jul 19, 2023.
What are the highest and lowest recorded NADAC prices for KONVOMEP 2-84 MG/ML ORAL SUSP?
Since Jul 19, 2023, the NADAC for KONVOMEP 2-84 MG/ML ORAL SUSP has ranged from a low of $1.8596 (Jul 19, 2023) to a high of $2.0875 (May 13, 2026), with a median of $2.0240 per ML.
Are there cheaper alternatives to KONVOMEP 2-84 MG/ML ORAL SUSP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, KONVOMEP 2-84 MG/ML ORAL SUSP, is $1.2468 per ML — about 40% below KONVOMEP 2-84 MG/ML ORAL SUSP.
Who manufactures KONVOMEP 2-84 MG/ML ORAL SUSP?
KONVOMEP 2-84 MG/ML ORAL SUSP (NDC 65628027203) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.